Literature DB >> 12409662

Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.

Guido Fitze1, Mandy Schierz, Jan Bredow, Hans D Saeger, Dietmar Roesner, Hans K Schackert.   

Abstract

OBJECTIVE: To describe a genotype-phenotype correlation in MEN2 families with germline mutations of codons 790/791 and discuss options for the therapeutic management of gene carriers. SUMMARY BACKGROUND DATA: Heredity of MEN2 syndromes is caused by a heterozygous germline mutation in the protooncogene. Rare mutations of codons 790/791 associated with incomplete penetrant MEN2A/FMTC phenotype were reported in five families, contraindicating the prophylactic thyroidectomy for the genetically affected children.
METHODS: Forty-five patients with a putative sporadic MTC were screened for germline mutations by direct DNA sequencing. Family members of identified index cases underwent genetic analysis. Gene carriers were examined clinically and biochemically, and all gene carriers underwent prophylactic thyroidectomy.
RESULTS: Five index patients were identified, four of whom harbored mutations in codons 790/791 and one in codon 634. In the kindreds, four L790F carriers and one Y791F carrier were detected. The thyroid gland histology of L790F carriers revealed medullary thyroid carcinoma in two patients (aged 29 and 50 years) and C-cell hyperplasia in two additional patients (aged 9 and 16 years). The Y791F carrier had a normal histology.
CONCLUSIONS: Codon 790/791 mutations had diverse penetrance. Whereas prophylactic thyroidectomy in children is a justifiable approach for codon 790 mutation carriers, the indication for thyroidectomy should depend on the clinical course of codon 791 carriers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12409662      PMCID: PMC1422614          DOI: 10.1097/00000658-200211000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  27 in total

1.  Association of RET protooncogene codon 45 polymorphism with Hirschsprung disease.

Authors:  G Fitze; M Schreiber; E Kuhlisch; H K Schackert; D Roesner
Journal:  Am J Hum Genet       Date:  1999-11       Impact factor: 11.025

2.  Genotype-phenotype correlations in hereditary medullary thyroid carcinoma: oncological features and biochemical properties.

Authors:  A Machens; O Gimm; R Hinze; W Höppner; B O Boehm; H Dralle
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

Review 3.  C-cell cancer--prevention and treatment.

Authors:  O Gimm; H Dralle
Journal:  Langenbecks Arch Surg       Date:  1999-02       Impact factor: 3.445

4.  Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?

Authors:  M K Frohnauer; R A Decker
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

5.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

Authors:  L F Lin; D H Doherty; J D Lile; S Bektesh; F Collins
Journal:  Science       Date:  1993-05-21       Impact factor: 47.728

6.  Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.

Authors:  H Donis-Keller; S Dou; D Chi; K M Carlson; K Toshima; T C Lairmore; J R Howe; J F Moley; P Goodfellow; S A Wells
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

7.  Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex.

Authors:  R H Baloh; M G Tansey; P A Lampe; T J Fahrner; H Enomoto; K S Simburger; M L Leitner; T Araki; E M Johnson; J Milbrandt
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

8.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.

Authors:  L M Mulligan; J B Kwok; C S Healey; M J Elsdon; C Eng; E Gardner; D R Love; S E Mole; J K Moore; L Papi
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

9.  Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.

Authors:  R Hinze; H J Holzhausen; O Gimm; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1998-09       Impact factor: 4.064

10.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.

Authors:  R M Hofstra; R M Landsvater; I Ceccherini; R P Stulp; T Stelwagen; Y Luo; B Pasini; J W Höppener; H K van Amstel; G Romeo
Journal:  Nature       Date:  1994-01-27       Impact factor: 49.962

View more
  16 in total

1.  Exon 5 of the RET proto-oncogene: a newly detected risk exon for familial medullary thyroid carcinoma, a novel germ-line mutation Gly321Arg.

Authors:  S Dvorakova; E Vaclavikova; J Duskova; P Vlcek; A Ryska; B Bendlova
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

2.  Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.

Authors:  Thereasa A Rich; Lei Feng; Naifa Busaidy; Gilbert J Cote; Robert F Gagel; Mimi Hu; Camilo Jimenez; Jeffrey E Lee; Nancy Perrier; Steven I Sherman; Steven G Waguespack; Anita Ying; Elizabeth Grubbs
Journal:  Thyroid       Date:  2014-06-06       Impact factor: 6.568

3.  The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease.

Authors:  Richard Skába; Sárka Dvoráková; Eliska Václavíková; Petr Vlcek; Miroslava Frantlová; Bela Bendlová
Journal:  Pediatr Surg Int       Date:  2006-12       Impact factor: 1.827

Review 4.  Molecular pathogenesis of MEN2-associated tumors.

Authors:  Christian A Koch
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system.

Authors:  Felix Rückert; Heike Görgens; Ines Richter; Dietmar Krex; Gabriele Schackert; Eberhard Kuhlisch; Guido Fitze; Hans-Detlev Saeger; Christian Pilarsky; Robert Grützmann; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

6.  Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.

Authors:  Junyi Wang; Bin Zhang; Wensheng Liu; Yongxia Zhang; Xuebing Di; Yanmei Yang; Dangui Yan
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

7.  Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?

Authors:  Peter Vestergaard; Else Marie Vestergaard; Helle Brockstedt; Peer Christiansen
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 8.  Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene.

Authors:  Andrea Frilling; Frank Weber; Carsten Tecklenborg; Christoph Erich Broelsch
Journal:  Langenbecks Arch Surg       Date:  2003-03-25       Impact factor: 3.445

9.  RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.

Authors:  Eliska Vaclavikova; Sarka Dvorakova; Vlasta Sykorova; Radovan Bilek; Katerina Dvorakova; Petr Vlcek; Richard Skaba; Tomas Zelinka; Bela Bendlova
Journal:  Endocrine       Date:  2009-10-14       Impact factor: 3.633

10.  Medullary thyroid cancer: RET testing of an archival material.

Authors:  Christian Godballe; Gita Jørgensen; Anne-Marie Gerdes; Annelise S Krogdahl; Anne Tybjaerg-Hansen; Finn C Nielsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.